Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The British Journal of Ophthalmology|March 27, 2002
Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growthS R Boyd, D S W Tan, L de Souza, et al.Lung Cancer (Amsterdam, Netherlands)|December 10, 2021
Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 studyD S-W Tan, M Thomas, D-W Kim, et al.ESMO Open|June 28, 2023
Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trialJ Rodon Ahnert, D S-W Tan, I Garrido-Laguna, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOSY-L Wu, D Planchard, S Lu, et al.British Journal of Cancer|April 26, 2012
Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumoursS Kaye, S Aamdal, R Jones, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2021
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancerA J Schoenfeld, S J Antonia, M M Awad, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 20, 2011
Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkersE-H Tan, C Goh, W T Lim, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2020
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancerJ J Lin, S V Liu, C E McCoach, et al.ESMO Open|June 25, 2023
Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working groupH H Loong, T Shimizu, A Prawira, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOSK Park, J Vansteenkiste, K H Lee, et al.Pageof 2